Artemis Medicare Services Q2 FY27: revenue up 13.2% to ₹311 Cr, net profit up 3.5% to ₹31 Cr
Results · Finvezto · 2 Nov 2026 · Artemis Medicare Services (ARTEMISMED)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 311 | - | +13.2% |
| Operating profit | 55 | - | +8.3% |
| Net profit | 31 | - | +3.5% |
| Operating margin | 17.6% | - | -0.8 pp |
| Net margin | 10.0% | - | -0.9 pp |
YoY is the company's own figure. QoQ shows where our quarterly series matches the filing.
Key points
- Consolidated revenue from operations for Q2 FY27 was INR 311 crores, up 13.2% year-on-year, supported by demand across key specialties like cardiac sciences, oncology, and transplants. Earnings call
- Consolidated EBITDA for Q2 FY27 stood at INR 62.89 crores with a margin of 20.2%, while profit after tax reached INR 31 crores, representing a year-on-year increase of 3.7%. Earnings call
- International patients contributed approximately 30% of revenue in Q2 FY27, serving patient bases from more than 150 countries. Earnings call
What to watch
- Management on operational capacity target: Along with Raipur and the Gurugram expansion, this facility supports our plan to increase our operational capacity to around 2,000 beds over the next 3 to 5 years.
- Management on south delhi project operational timeline: So, but we will be FY Q4, FY29-30 is when we are looking to operationalize it and we stand by that.
Links
Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.